Oncolytics shareholders OK continuance to BC and domestication to Nevada

ONCOLYTICS BIOTECH INC

Continuance from Alberta to British Columbia approved: 85.21% in favor.
Domestication from British Columbia to Nevada approved: 86.98% in favor.
2026 Incentive Award Plan approved (76.77% in favor), conditional on completion of continuance and domestication.
Company expects to complete continuance and domestication by end of Q1 2026.

item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-004103
form_type: 8-K
ticker: ONCY
cik: 0001129928
company_name: ONCOLYTICS BIOTECH INC
filed_at: 2026-01-15T23:59:59+00:00
discovered_at: 2026-05-14T18:02:34.594162+00:00
generated_at: 2026-05-16T10:04:24.081873+00:00
sec_items: ["5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-004103
json_url: https://secwatch.observer/filing/0001104659-26-004103.json
markdown_url: https://secwatch.observer/filing/0001104659-26-004103.md
text_url: https://secwatch.observer/filing/0001104659-26-004103.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1129928/000110465926004103/0001104659-26-004103-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1129928/000110465926004103/tm263290d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

DUOT

Duos Tech annual meeting: all five director nominees elected, auditor ratified

DUOS TECHNOLOGIES GROUP, INC. June 2, 2026, 8:30 AM ET other_material Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MPT

MPT shareholders elect all directors, approve say-on-pay and equity plan with notable opposition

MEDICAL PROPERTIES TRUST INC June 1, 2026, 4:55 PM ET other_material Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

LODE

Comstock holds AGM; all director nominees elected, auditor and equity plan approved

Comstock Inc. June 1, 2026, 4:15 PM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BRUN

Boost Run files 8-K referencing investor presentation; exhibit content not included in filing

Boost Run Inc. June 2, 2026, 8:30 AM ET other_material Items 2.02, 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

SRTS

Sensus Healthcare shareholders re-elect directors, approve advisory vote on pay, ratify auditor

Sensus Healthcare, Inc. June 2, 2026, 8:26 AM ET other_material Items 5.07

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

BCO

Brink's updates investor slides; reaffirms prior guidance

BRINKS CO June 2, 2026, 6:20 AM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

NWSA

News Corp continues $1B buyback; repurchases ~100K shares on June 1, 2026

NEWS CORP June 1, 2026, 7:59 PM ET other_material Items 8.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

WORLD FINANCIAL NETWORK CREDIT CARD MASTER NOTE TRUST

Comenity Bank and Servicer amend service agreement on issue management metrics effective June 1, 2026

WORLD FINANCIAL NETWORK CREDIT CARD MASTER NOTE TRUST June 1, 2026, 5:35 PM ET other_material Items 1.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-26-004103

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.